DASGIP Parallel Bioreactor Systems for Unparalleled Results
DASGIP AG develops and manufactures technologically superior parallel bioreactor systems designed for the lab-scale cultivation of bacterial, mammalian and human cells.
Process engineers, researchers and product development specialists who work with biotechnology processes rely on DASGIP parallel bioreactor systems to drive their projects forward, thus benefiting from increased cell and media productivity, reproducible and scalable results, and shortened innovation cycles.
Integrated DoE for Benchtop Bioreactors
The integration of industry-leading DoE software JMP with the DASGIP Benchtop Bioreactor Control.
-
16.01.2012
DASGIP's Product Catalog 2012 downloadable -
12.01.2012
DASGIP supports scholarship program -
05.01.2012
Eppendorf acquires DASGIP Group
References
More and more commercial enterprises and research institutes in the fields of biotechnology, pharmaceuticals, chemicals and cosmetics, as well as food and animal feed, are benefiting from DASGIP technology. By now, nine of the ten worldwide leading pharmaceutical companies are among our customer base.